Office
1223 16th St, Santa Monica, CA 90404
(424) 259-8859
Internal medicine in Valencia, CA · The Regents of the University of California
No reviews yet. Be the first to review
1223 16th St, Santa Monica, CA 90404
(424) 259-8859
87.5 out of 100 in Medicare’s Merit-based Incentive Payment System for 2024 (practice group score). Medicare Care Compare
In 2025, drug and medical-device companies reported $107,487 in general payments to Rena Desai Callahan (102 payments). Largest: Gilead Sciences, Inc. ($38,950); Stemline Therapeutics Inc. ($27,768); AstraZeneca Pharmaceuticals LP ($26,414). Reported under the federal Open Payments program.
Billed services and units in Original Medicare Part B, 2024.
Scroll the table sideways to see every column.
| HCPCS | Billed services / units | Beneficiaries in this row | Service description (English) | Billing setting |
|---|---|---|---|---|
| 36415 | 233 | 91 | Insertion of needle into vein for collection of blood sample | Non-facility |
| 85025 | 431 | 145 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Non-facility |
| 96361 | 25 | 11 | Infusion into a vein for hydration, each additional hour | Non-facility |
| 96365 | 124 | 57 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Non-facility |
| 96366 | 75 | 14 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Non-facility |
| 96367 | 141 | 30 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Non-facility |
| 96372 | 114 | 45 | Injection of drug or substance under skin or into muscle | Non-facility |
| 96375 | 286 | 41 | Injection of additional new drug or substance into vein | Non-facility |
| 96402 | 297 | 25 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Non-facility |
| 96413 | 226 | 59 | Administration of chemotherapy into vein, 1 hour or less | Non-facility |
| 96415 | 39 | 11 | Administration of chemotherapy into vein, each additional hour | Non-facility |
| 96417 | 72 | 19 | Administration of additional new drug or substance into vein, 1 hour or less | Non-facility |
| 99205 | 61 | 61 | New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more | Non-facility |
| 99214 | 1,121 | 409 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | Non-facility |
| 99215 | 139 | 84 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | Non-facility |
Scroll the table sideways to see every column.
| HCPCS | Billed services / units | Beneficiaries in this row | Service description (English) | Billing setting |
|---|---|---|---|---|
| 99223 | 22 | 22 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility |
| 99233 | 33 | 21 | Subsequent hospital care with moderate level of medical decision making, if using time, at least 50 minutes | Facility |
| 99421 | 45 | 40 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Non-facility |
| G2211 | 827 | 387 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Non-facility |
Drug units follow each billing code’s definition.
Scroll the table sideways to see every column.
| HCPCS | Drug billing units | Beneficiaries in this row | Service description (English) | Billing setting |
|---|---|---|---|---|
| J0897 | 7,860 | 30 | Injection, denosumab, 1 mg | Non-facility |
| J1100 | 942 | 26 | Injection, dexamethasone sodium phosphate, 1 mg | Non-facility |
| J1200 | 116 | 28 | Injection, diphenhydramine hcl, up to 50 mg | Non-facility |
| J1453 | 7,050 | 15 | Injection, fosaprepitant, 1 mg | Non-facility |
| J2405 | 552 | 17 | Injection, ondansetron hydrochloride, per 1 mg | Non-facility |
| J2469 | 600 | 20 | Injection, palonosetron hcl, 25 mcg | Non-facility |
| J3489 | 136 | 27 | Injection, zoledronic acid, 1 mg | Non-facility |
| J7050 | 322 | 55 | Infusion, normal saline solution, 250 cc | Non-facility |
| J9394 | 1,500 | 20 | Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg | Non-facility |
| J9395 | 1,400 | 18 | Injection, fulvestrant, 25 mg | Non-facility |
The office is at 1223 16th St, Santa Monica, CA 90404.
The office phone is (424) 259-8859.
Specialty: Internal medicine.
Yes. Rena Desai Callahan billed Original Medicare Part B services in 2024 (see Medicare activity above).
Rena Desai Callahan is affiliated with Ronald Reagan UCLA Medical Center (Los Angeles, CA); Henry Mayo Newhall Hospital (Valencia, CA); Santa Monica - UCLA Med Ctr & Orthopaedic Hospital (Santa Monica, CA); UCLA West Valley Medical Center (West Hills, CA).
Yes. Rena Desai Callahan offers telehealth visits.
Yes. Rena Desai Callahan is accepting new patients.
All reviews are moderated. Review policy